<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Klement K</submitter><funding>Deutsche Forschungsgemeinschaft</funding><funding>Wilhelm Sander-Stiftung</funding><funding>Friedrich-Alexander-Universität Erlangen-Nürnberg</funding><funding>IZKF</funding><pagination>jcs261214</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10652037</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>136(20)</volume><pubmed_abstract>Axin (also known as AXIN1) is a central negative regulator of the proto-oncogenic Wnt/β-catenin signaling pathway, as axin condensates provide a scaffold for the assembly of a multiprotein complex degrading β-catenin. Axin, in turn, is degraded through tankyrase. Consequently, tankyrase small-molecule inhibitors block Wnt signaling by stabilizing axin, revealing potential for cancer therapy. Here, we discovered that axin is phosphorylated by casein kinase 1 alpha 1 (CSNK1A1, also known as CK1α) at an N-terminal casein kinase 1 consensus motif, and that this phosphorylation is antagonized by the catalytic subunit alpha of protein phosphatase 1 (PPP1CA, hereafter referred to as PP1). Axin condensates promoted phosphorylation by enriching CK1α over PP1. Importantly, the phosphorylation took p</pubmed_abstract><journal>Journal of cell science</journal><pubmed_title>Phosphorylation of axin within biomolecular condensates counteracts its tankyrase-mediated degradation.</pubmed_title><pmcid>PMC10652037</pmcid><funding_grant_id>D30</funding_grant_id><funding_grant_id>BE 7055/2-1</funding_grant_id><funding_grant_id>2018.017.2</funding_grant_id><pubmed_authors>Bruckner M</pubmed_authors><pubmed_authors>Klement K</pubmed_authors><pubmed_authors>Bernkopf DB</pubmed_authors></additional><is_claimable>false</is_claimable><name>Phosphorylation of axin within biomolecular condensates counteracts its tankyrase-mediated degradation.</name><description>Axin (also known as AXIN1) is a central negative regulator of the proto-oncogenic Wnt/β-catenin signaling pathway, as axin condensates provide a scaffold for the assembly of a multiprotein complex degrading β-catenin. Axin, in turn, is degraded through tankyrase. Consequently, tankyrase small-molecule inhibitors block Wnt signaling by stabilizing axin, revealing potential for cancer therapy. Here, we discovered that axin is phosphorylated by casein kinase 1 alpha 1 (CSNK1A1, also known as CK1α) at an N-terminal casein kinase 1 consensus motif, and that this phosphorylation is antagonized by the catalytic subunit alpha of protein phosphatase 1 (PPP1CA, hereafter referred to as PP1). Axin condensates promoted phosphorylation by enriching CK1α over PP1. Importantly, the phosphorylation took p</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Oct</publication><modification>2026-05-29T10:23:42.779Z</modification><creation>2025-04-04T11:02:33.729Z</creation></dates><accession>S-EPMC10652037</accession><cross_references><pubmed>37721093</pubmed><doi>10.1242/jcs.261214</doi></cross_references></HashMap>